Literature DB >> 18544206

Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.

C Pheiffer1, N M Carroll, N Beyers, P Donald, K Duncan, P Uys, P van Helden.   

Abstract

OBJECTIVE: To investigate whether time to detection (TTD) of Mycobacterium tuberculosis in BACTEC Mycobacteria Growth Indicator Tube (MGIT) 960 and BACTEC 460 TB systems can be used as an alternative to colony-forming unit (cfu) counting.
DESIGN: A single sputum sample recovered from each of 22 patients with tuberculosis (TB) was cultured on Middlebrook 7H11 agar and in BACTEC MGIT 960 and BACTEC 460 to investigate the relationship between cfu/ml and TTD. The relationship between TTD and treatment response was investigated by culturing a single sputum sample from each of 125 patients with TB in the BACTEC 460 system and comparing TTD values with their treatment response.
RESULTS: An inverse correlation between TTD and bacterial number, as assessed by inoculum size and cfu/ml, was observed. For the 125 patients followed up during treatment, TTD values at diagnosis correlated with smear conversion rates at 2 months and treatment outcomes. Drug resistance of the infecting strain was associated with decreased killing, as indicated by the delayed increase in TTD during the first few days of treatment.
CONCLUSION: The TTD of M. tuberculosis in BACTEC MGIT 960 and BACTEC 460 TB systems is a viable alternative to colony counting. TTD in liquid culture will facilitate mycobacterial quantification, especially in the evaluation of early bactericidal activity.

Entities:  

Mesh:

Year:  2008        PMID: 18544206

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  40 in total

1.  Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapy.

Authors:  Charles M Bark; Bonnie A Thiel; John L Johnson
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.

Authors:  Grant Theron; Lancelot Pinto; Jonny Peter; Hemant Kumar Mishra; Hridesh Kumar Mishra; Richard van Zyl-Smit; Surendra Kumar Sharma; Keertan Dheda
Journal:  Clin Infect Dis       Date:  2011-12-01       Impact factor: 9.079

3.  Plasma drug activity assay for treatment optimization in tuberculosis patients.

Authors:  Scott K Heysell; Charles Mtabho; Stellah Mpagama; Solomon Mwaigwisya; Suporn Pholwat; Norah Ndusilo; Jean Gratz; Rob E Aarnoutse; Gibson S Kibiki; Eric R Houpt
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

4.  Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.

Authors:  A H Diacon; J S Maritz; A Venter; P D van Helden; K Andries; D F McNeeley; P R Donald
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-04       Impact factor: 3.267

5.  Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients.

Authors:  Andreas H Diacon; Rodney Dawson; Madeleine Hanekom; Kim Narunsky; Stefan J Maritz; Amour Venter; Peter R Donald; Christo van Niekerk; Karl Whitney; Doris J Rouse; Martino W Laurenzi; Ann M Ginsberg; Melvin K Spigelman
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

6.  Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.

Authors:  Marc Weiner; Thomas J Prihoda; William Burman; John L Johnson; Stefan Goldberg; Nesri Padayatchi; Paula Duran; Melissa Engle; Grace Muzanye; Roy D Mugerwa; A Willem Sturm
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

7.  A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Pamela Nabeta; Amy L Davidow; Viral Vadwai; Rasim Tahirli; Vanisha Munsamy; Mark Nicol; Martin Jones; David H Persing; Doris Hillemann; Sabine Ruesch-Gerdes; Felicity Leisegang; Carlos Zamudio; Camilla Rodrigues; Catharina C Boehme; Mark D Perkins; David Alland
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

8.  Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.

Authors:  K Kolibab; A Yang; M Parra; S C Derrick; S L Morris
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

9.  Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.

Authors:  Emmanuel Chigutsa; Jotam G Pasipanodya; Marianne E Visser; Paul D van Helden; Peter J Smith; Frederick A Sirgel; Tawanda Gumbo; Helen McIlleron
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

10.  Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes.

Authors:  Matheus de Matto Pires; Giovana Rodrigues Pereira; Márcia Silva Barbosa; Natan José Dutra Dias; Carina Secchi; Jociane Saldanha Hoff; Denise Rossato Silva
Journal:  Lung       Date:  2020-10-31       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.